-
Fine chemicals japan 2020, Booth No.2D-31
-
ShangHai,Dec.16 to Dec.18,booth No:e3D89
-
CPHI China 2019 Jun. 18 to Jun.20, Booth No.
Pharmaceutical Raw Materials
Postion:Home > Product
Pharmaceutical Raw Materials
| CAS No. | Product Name | |
|---|---|---|
| 1 | Selexipag Intermediate | |
| 475086-75-0 | 4-[(5,6-Diphenylpyrazinyl)(1-methylethyl)amino]-1-butanol | |
| 475086-75-0 | 4-[(5,6-Diphenylpyrazinyl)(1-methylethyl)amino]-1-butanol | |
| 2 | Rivocaranib intermediate | |
| 3731-53-1 | 4-Pyridinemethaneamine | |
| 3 | Enzalutamide intermediate | |
| 143782-23-4 | 4-isothiocyanato-2-(trifluoroMethyl)benzonitrile | |
| 4 | Maraviroc intermediate | |
| 122665-97-8 | 4,4-Difluorocyclohexanecarboxylic acid | |
| 5 | Rizatriptan Intermediate | |
| 6139-83-9 | 4-Chlorobutanal diethyl acetal | |
| 6 | Velpatasvir intermediate | |
| 1378391-45-7 | (2S,4S)-2-[5-[1,11-Dihydro-2-[(2S,5S)-1-[(2S)-2-[(methoxycarbonyl)amino]-3-methyl-1-oxobutyl]-5-methyl-2-pyrrolidinyl][2]benzopyrano[4',3':6,7]naphth[1,2-d]imidazol-9-yl]-1H-imidazol-2-yl]-4-(methoxym | |
| 1438383-89-1 | 9-Bromo-3-(2-Bromo Acetyl)-10,11-Dihydro-5H-dibenzo(c,g) Chromen-8(9H)-one | |
| 1378388-16-9 | (2S,4S)-1-(tert-butoxycarbonyl)-4-(MethoxyMethyl)pyrrolidine-2-carboxylic acid | |
| 1335316-40-9 | (2S,5S)-1-((methoxycarbonyl)-L-valyl)-5-methylpyrrolidine-2-carboxylic acid | |
| 7 | Dinoprost intermediate | |
| 26054-67-1 | (3aR,4R,5R,6aS)-hexahydro-5-hydroxy-4-[(1E,3S)-3-hydroxy-1-octen-1-yl]-2H-Cyclopenta[b]furan-2-one | |
| 64072-30-6 | (3aR,4R,5R,6aS)-5-((tert-butyldimethylsilyl)oxy)-4-((S,E)-3-hydroxyoct-1-ene-1-yl)hexahydro-2H-cyclopenta[b]furan-2-one | |
| 64072-25-9 | (3aR,4R,5R,6aS)-5-((tert-butyldimethylsilyl)oxy)-4-((E)-3-oxohex-1-en-1-yl)hexahydro-2H-cyclopenta[b]furan-2-one | |
| 8 | Fluvoxamine Maleate Intermediate | |
| 61718-80-7 | 5-Methoxy-1-[4-(Trifluoromethyl)Phenyl]-1-Pentanone | |
| 9 | Voglibose intermediate | |
| 83465-22-9 | Valiolamine | |
| 83470-76-2 | (R)-(-)-3-Quinuclidinol | |
| 38231-86-6 | (1S)-1-Phenyl-1,2,3,4-tetrahydroisoquinoline | |
| 10 | Silodosin Intermediates | |
| 496-15-1 | Indoline | |
| 11 | Epinastine Intermediate | |
| 127785-96-0 | 6-Aminomethyl-6,11-dihydro-5H-dibenz[b,e]azepine (E)-2-butenedioate | |
| 12 | Enticavir intermediate | |
| 1354715-02-8 | (1R,3R,4S)-4-(benzyloxy)-3-((benzyloxy)methyl)-2-methylenecyclopentan-1-ol | |
| 701278-56-0 | Cyclopentanol, 4-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-3-[[[(1,1-dimethylethyl)dimethylsilyl]oxy]methyl]-2-methylene-, (1R,3R,4S)- | |
| 204845-95-4 | 6-(Benzyloxy)-9-[(1S,3R,4S)-2-methylene-4-(phenylmethoxy)-3-[(phenylmethoxy)methyl]cyclopentyl]-9H-purine-2-amine | |
| 142217-79-6 | (2R,3S,5S)-3-(Benzyloxy)-5-[2-[[(4-methoxyphenyl)diphenylmethyl]amino]-6-(benzyloxy)-9H-purin-9-yl]-2-(benzyloxymethyl)cyclopentanone | |
| 1233193-58-2 | (1R,3R,4S)-4-(tert-butyldiphenylsilyloxy)-2-Methylene-3-(trityloxyMethyl)cyclopentanol | |
| 142217-78-5 | (2R,3S,5S)-3-(Benzyloxy)-5-[2-[[(4-methoxyphenyl)diphenylmethyl]amino]-6-(phenylmethoxy)-9H-purin-9-yl]-2-(benzyloxymethyl)cyclopentanol | |
| 110567-22-1 | (1S,2R,3S,5R)-3-(Phenymethyloxy)-2-(phenylmethoxy)methyl-6-oxabicyclo[3.1.0]hexane | |
| 142217-77-4 | (1S,2S,3S,5S)-5-(2-Amino-6-(benzyloxy)-9H-purin-9-yl)-3-(benzyloxy)-2-(benzyloxymethyl)cyclopentanol | |
| 142217-80-9 | 6-(Benzyloxy)-9-((1S,3R,3S)-4-(benzyloxy)-3-(benzyloxymethyl)-2-methylenecyclopentyl)-N-((4-methoxyphenyl)diphenylmethyl)-9H-purin-2-amine | |
| 142217-81-0 | 2-Amino-1,9-dihydro-9-[(1S,3R,4S)-4-(benzyloxy)-3-(benzyloxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one | |
| 13 | Eldecalcitol Intermediate | |
| 70550-73-1 | (1R,3aR,7aR)-1-((R)-6-hydroxy-6-Methylheptan-2-yl)-7a-Methylhexahydro-1H-inden-4(2H)-one | |
| 1204819-64-6 | (3aR,7aR)-1-((R)-6-(methoxymethoxy)-6-methylheptan-2-yl)-3a,7a-dimethyloctahydro-4H-inden-4-one | |
| 200636-54-0 | ((Z)-((3S,4S,5R)-5-((tert-butyldimethylsilyl)oxy)-4-(4-((tert-butyldimethylsilyl)oxy)butyl)-3-methyl-2-methylenecyclohexylidene)methyl)diphenylphosphine oxide | |
| 14 | Etizolam Intermediate | |
| 40018-25-5 | 2-Chlorobenzoylacetonitrile | |
| 50508-60-6 | 2-Amino-3-(2-chlorobenzoyl)-5-ethylthiophene | |
| 15 | Moxonidine intermediate | |
| 75438-54-9 | 4,6-dichloro-2-methyl-5-(1-acetyl-2-imidazoline-2-yl)aminopyrimidine | |
| 16 | Efinaconazole intermediate | |
| 133775-25-4 | (2R,3R)-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butane-2,3-diol | |
| 144230-50-2 | 4-Methylenepiperidine HCl | |
| 241479-73-2 | (2R,3S)-2-(2,5-difluorophenyl)-3-methyl-2-[(1H-1,2,4-triazol-1-yl)-methyl]-oxirane | |
| 17 | Lumefantrine(Benflumetol) Intermediate | |
| 607-97-6 | Ethyl 2-ethylacetoacetate | |
| 69759-61-1 | 2,7-Dichloro-alpha-[(dibutylamino)methyl]-9H-fluorene-4-methanol | |
| 18 | Olmesartan intermediate | |
| 144689-93-0 | ethyl 4-(2-hydroxypropan-2-yl)-2-propyl-1H-imidazole-5-carboxylate | |
| 5465-29-2 | 2-Propylbenzimidazole | |
| 144690-92-6 | Trityl Olmesartan Medoxomil | |
| 124750-51-2 | 5-[4'-(Bromomethyl)[1,1'-Biphenyl]-2-Yl]-2-(Triphenylmethyl)-2H-Tetrazole | |
| 144689-94-1 | 1H-Imidazole-4,5-Dicarboxylic Acid, 2-Propyl-, Diethyl Ester | |
| 80841-78-7 | 4-Chloromethyl-5-Methyl-1,3-Dioxol-2-One | |
| 19 | Sarpogrelate intermediate | |
| 143212-74-2 | 2-[2-(3-Methoxyphenyl)ethenyl]phenol | |
| 167145-13-3 | 2-(2-(3-Methoxy)Phenylethyl)Phenol | |
| 135261-74-4 | 2-[[3-(Dimethylamino)-2-Hydroxypropoxy]Phenyl]Ethyl-3-Methoxybenzene Hydrochloride | |
| 20 | Bosentan Hydrate Intermediate | |
| 150728-13-5 | 4,6-Dichloro-5-(2-methoxyphenoxy)-2,2'-bipyrimidine | |
| 301646-59-3 | 4-tert-Butyl-N-(6-chloro-5-(2-methoxyphenoxy)-2,2'-bipyrimidin-4-yl)benzenesulfonamide potassium salt? | |
| 21 | All kinds of prostaglandins intermediates | |
| 22 | Active Pharmaceutical Ingredients | |
| 209860-87-7 | Tafluprost | |
| 19767-45-4 | Mesna | |
| 155206-00-1 | Bimatoprost | |
| 139404-48-1 | Tiotropium Bromide Monohydrate | |
| 54965-21-8 | Albendazole | |
